323 related articles for article (PubMed ID: 26773235)
1. Mechanism of isoniazid-induced hepatotoxicity: then and now.
Metushi I; Uetrecht J; Phillips E
Br J Clin Pharmacol; 2016 Jun; 81(6):1030-6. PubMed ID: 26773235
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of isoniazid: The good, the bad, and the alternatives.
Erwin ER; Addison AP; John SF; Olaleye OA; Rosell RC
Tuberculosis (Edinb); 2019 May; 116S():S66-S70. PubMed ID: 31076322
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Sanders C; ; Lee WM; Uetrecht J
Hepatology; 2014 Mar; 59(3):1084-93. PubMed ID: 23775837
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP3A in isoniazid metabolism in vivo.
Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X
Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716
[TBL] [Abstract][Full Text] [Related]
5. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
[TBL] [Abstract][Full Text] [Related]
6. IgG3 is the dominant subtype of anti-isoniazid antibodies in patients with isoniazid-induced liver failure.
Metushi IG; Lee WM; Uetrecht J
Chem Res Toxicol; 2014 May; 27(5):738-40. PubMed ID: 24786179
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity mechanisms of isoniazid: A mini-review.
Hassan HM; Guo HL; Yousef BA; Luyong Z; Zhenzhou J
J Appl Toxicol; 2015 Dec; 35(12):1427-32. PubMed ID: 26095833
[TBL] [Abstract][Full Text] [Related]
8. Mild isoniazid-induced liver injury in humans is associated with an increase in Th17 cells and T cells producing IL-10.
Metushi IG; Zhu X; Chen X; Gardam MA; Uetrecht J
Chem Res Toxicol; 2014 Apr; 27(4):683-9. PubMed ID: 24564876
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid-induced liver injury and immune response in mice.
Metushi IG; Uetrecht J
J Immunotoxicol; 2014 Oct; 11(4):383-92. PubMed ID: 24303880
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid-induced hepatotoxicity in children with latent tuberculosis infection.
Devrim İ; Devrim F; Bayram N; Aktürk H; Aksay A; Can D; Apa H
Minerva Pediatr (Torino); 2021 Apr; 73(2):184-187. PubMed ID: 26377643
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury.
Liu N; Liu J; Zheng B; Zeng X; Ye Z; Huang X; Liu W; Liu Y; Fang Q; Chen L; Rao T; Ouyang D
Biomed Pharmacother; 2023 Apr; 160():114400. PubMed ID: 36805186
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
Boelsterli UA; Lee KK
J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
[TBL] [Abstract][Full Text] [Related]
13. Isoniazid-related hepatitis.
Vasudeva R; Woods B
Dig Dis; 1997; 15(6):357-67. PubMed ID: 9439900
[TBL] [Abstract][Full Text] [Related]
14. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of isoniazid-induced hepatotoxicity.
Perwitasari DA; Atthobari J; Wilffert B
Drug Metab Rev; 2015 May; 47(2):222-8. PubMed ID: 26095714
[TBL] [Abstract][Full Text] [Related]
16. Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity.
Hayashi PH; Fontana RJ; Chalasani NP; Stolz AA; Talwalkar JA; Navarro VJ; Lee WM; Davern TJ; Kleiner DE; Gu J; Hoofnagle JH;
Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1676-82.e1. PubMed ID: 25724701
[TBL] [Abstract][Full Text] [Related]
17. CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients.
Perwitasari DA; Irham LM; Darmawan E; Mulyani UA; Atthobari J
Indian J Tuberc; 2016 Jul; 63(3):139-143. PubMed ID: 27865233
[TBL] [Abstract][Full Text] [Related]
18. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
Gray EL; Goldberg HF
Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.
Vuilleumier N; Rossier MF; Chiappe A; Degoumois F; Dayer P; Mermillod B; Nicod L; Desmeules J; Hochstrasser D
Eur J Clin Pharmacol; 2006 Jun; 62(6):423-9. PubMed ID: 16770646
[TBL] [Abstract][Full Text] [Related]
20. Hepatotoxicity Induced by Isoniazid-Lipopolysaccharide through Endoplasmic Reticulum Stress, Autophagy, and Apoptosis Pathways in Zebrafish.
Zhang Y; Cen J; Jia Z; Hsiao CD; Xia Q; Wang X; Chen X; Wang R; Jiang Z; Zhang L; Liu K
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
